The purpose of this award is to support highly innovative research ideas that have a clear potential to produce high-impact results, but that have little or no preliminary data to successfully compete for funding from other sources. This award is not intended to support ongoing research in the applicant’s laboratory, but rather support new ideas or approaches that have not previously been studied.
Clinical/Translational/Outcomes and Basic Science projects will be evaluated independently, with separate funding reserved for each category.
Additional dedicated funding to advance research activities in autoimmune hepatitis is available for the 2024 Awards cycle. Applications in autoimmune hepatitis are encouraged in all early to mid-career research award categories and the Pilot and Autoimmune Exploratory Research Award categories.
Application Deadline: Dec. 4, 2023